TransMedics, an Andover, MA, developer of systems for transporting organs for transplant, has pulled in $35.4 million in an equity offering that includes about $9 million from convertible debt, according to an SEC filing. Partners of Flagship Ventures, Foundation Capital, and Kleiner Perkins Caufield & Byers are listed as directors on the filing, which the company declined to comment on further at this time. In 2008, TransMedics withdrew its plans for an initial public offering worth up to $86 million, due to unfavorable market conditions.
Author: Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
View all posts by Erin Kutz
